The FDA has authorized a new treatment that may help immunocompromised people be protected from COVID-19. The treatment is a monoclonal antibody infusion that is expected to be available this April.
An antibody infusion therapy designed to help coronavirus patients recover faster may actually prevent people from getting the virus. A new clinical trial conducted by the University of North Carolina ...
Monoclonal antibodies target specific disease molecules. They can help treat cancer, autoimmune disorders, and infectious diseases. Discover what you should know about this therapy. Monoclonal ...
In a recent study posted to the medRxiv* preprint server, researchers comparatively evaluated antibody (Ab) responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among ...
For patients who rely on monoclonal antibodies and other biologic drugs, treatment often means hours tethered to an IV pole while a clear bag slowly empties into a vein. A new generation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results